AU655840B2 - 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents - Google Patents

2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents Download PDF

Info

Publication number
AU655840B2
AU655840B2 AU23225/92A AU2322592A AU655840B2 AU 655840 B2 AU655840 B2 AU 655840B2 AU 23225/92 A AU23225/92 A AU 23225/92A AU 2322592 A AU2322592 A AU 2322592A AU 655840 B2 AU655840 B2 AU 655840B2
Authority
AU
Australia
Prior art keywords
carbons
group
hydroxy
alkyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU23225/92A
Other languages
English (en)
Other versions
AU2322592A (en
Inventor
Willard Mckowan Welch Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of AU2322592A publication Critical patent/AU2322592A/en
Application granted granted Critical
Publication of AU655840B2 publication Critical patent/AU655840B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU23225/92A 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents Ceased AU655840B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73157791A 1991-07-17 1991-07-17
US731577 1991-07-17
PCT/US1992/004973 WO1993002052A1 (en) 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Publications (2)

Publication Number Publication Date
AU2322592A AU2322592A (en) 1993-02-23
AU655840B2 true AU655840B2 (en) 1995-01-12

Family

ID=24940103

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23225/92A Ceased AU655840B2 (en) 1991-07-17 1992-06-19 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents

Country Status (22)

Country Link
EP (1) EP0594729A1 (zh)
JP (1) JP2571904B2 (zh)
KR (1) KR0165003B1 (zh)
CN (1) CN1043759C (zh)
AU (1) AU655840B2 (zh)
BR (1) BR9206272A (zh)
CA (1) CA2113568A1 (zh)
CZ (1) CZ284133B6 (zh)
EG (1) EG20048A (zh)
FI (2) FI940192A (zh)
HU (1) HUT70528A (zh)
IE (1) IE922311A1 (zh)
IL (1) IL102473A (zh)
MX (1) MX9204190A (zh)
NO (1) NO180445C (zh)
NZ (1) NZ243580A (zh)
PL (1) PL169884B1 (zh)
PT (1) PT100689B (zh)
RU (1) RU2065859C1 (zh)
TW (1) TW201732B (zh)
WO (1) WO1993002052A1 (zh)
ZA (1) ZA925306B (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436255A (en) * 1992-07-23 1995-07-25 Pfizer Inc. Method of treating diseases susceptable to treatment by blocking NMDA-receptors
BR9307331A (pt) * 1992-10-30 1999-05-25 Pfizer Compostos neuroprotetores 3,4-dihidro-2(1ho-quinolona
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
WO2000061558A1 (fr) * 1999-04-09 2000-10-19 Mochida Pharmaceutical Co., Ltd. Remedes pour douleurs neurogenes
US6316474B1 (en) 1999-10-29 2001-11-13 Merck & Co., Inc. 2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
US6432976B1 (en) 1999-10-29 2002-08-13 Merck & Co., Inc. 8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
US6369076B1 (en) 1999-10-29 2002-04-09 Merck & Co. Inc. 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
US6489477B1 (en) 1999-10-29 2002-12-03 Merck & Co., Inc. 2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
US6380205B1 (en) 1999-10-29 2002-04-30 Merck & Co., Inc. 2-cyclohexyl quinazoline NMDA/NR2B antagonists
US6476041B1 (en) 1999-10-29 2002-11-05 Merck & Co., Inc. 1,4 substituted piperidinyl NMDA/NR2B antagonists
CA2386441A1 (en) 1999-10-29 2001-05-03 Merck Sharp & Dohme Limited Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
US6291499B1 (en) 1999-10-29 2001-09-18 Merck & Co., Inc. 2-cyclohexyl benzimidazole NMDA/NR2B antagonists
US6495561B2 (en) 1999-10-29 2002-12-17 Merck & Co., Inc. 2-cyclohexyl imidazopyridine NMDA/NR2B antagonists
SI1379520T1 (sl) 2001-02-23 2006-08-31 Merck & Co Inc N-substituirani nonaril-heterociklicni NMDA/NR2B antagonisti
WO2002080928A1 (en) 2001-04-03 2002-10-17 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
CA2507509A1 (en) 2002-11-25 2004-06-10 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient
JP2007508288A (ja) * 2003-10-08 2007-04-05 ファイザー株式会社 縮合ラクタム化合物
TWI409289B (zh) 2010-09-02 2013-09-21 Taiwan Union Technology Corp 由氮氧雜環化合物所製得之聚合物之穩態溶液及其製法與用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH17194A (en) * 1980-03-06 1984-06-19 Otsuka Pharma Co Ltd Novel carbostyril derivatives,and pharmaceutical composition containing the same
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
EP0398578B1 (en) * 1989-05-17 1997-03-12 Pfizer Inc. 2-piperidino-1-alkanol derivatives as antiischemic agents
CA2080475C (en) * 1990-05-10 2001-04-17 Bertrand Leo Chenard Neuroprotective indolone and related derivatives

Also Published As

Publication number Publication date
ZA925306B (en) 1994-01-17
KR0165003B1 (en) 1999-01-15
IL102473A0 (en) 1993-01-14
NO940144D0 (no) 1994-01-14
CN1043759C (zh) 1999-06-23
JPH06504293A (ja) 1994-05-19
TW201732B (zh) 1993-03-11
NO940144L (no) 1994-01-14
IL102473A (en) 1997-07-13
FI940192A0 (fi) 1994-01-14
EG20048A (en) 1997-03-27
BR9206272A (pt) 1995-04-11
CN1068566A (zh) 1993-02-03
FI940192A (fi) 1994-01-14
IE922311A1 (en) 1993-01-27
EP0594729A1 (en) 1994-05-04
NZ243580A (en) 1994-10-26
PL169884B1 (pl) 1996-09-30
MX9204190A (es) 1993-01-01
RU2065859C1 (ru) 1996-08-27
FI981956A (fi) 1998-09-11
AU2322592A (en) 1993-02-23
PT100689B (pt) 1999-06-30
CZ400892A3 (en) 1994-03-16
NO180445C (no) 1997-04-23
CA2113568A1 (en) 1993-02-04
CZ284133B6 (cs) 1998-08-12
PT100689A (pt) 1993-10-29
WO1993002052A1 (en) 1993-02-04
NO180445B (no) 1997-01-13
HU9400136D0 (en) 1994-05-30
JP2571904B2 (ja) 1997-01-16
HUT70528A (en) 1995-10-30
FI981956A0 (fi) 1998-09-11

Similar Documents

Publication Publication Date Title
AU655840B2 (en) 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
JPS58118582A (ja) ２−〔４−〔（４，４−ジアルキル−２，６−ピペリジンジオン−１−イル）ブチル〕−１−ピペラジニル〕ピリミジン
JPH02273676A (ja) 新規化合物、その製法及びそれを含む医薬組成物
WO2006082456A1 (en) Cyclohexylamides as dopamine d3 , d2 and 5ht1a antagonists
EP0070171B1 (en) Novel piperidine derivatives, processes for preparation thereof and pharmaceutical compositions containing same
EP1049694B1 (en) Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
EP0319429B1 (en) 9-Acylamino-tetrahydroacridine derivatives and memory enhancing agent containing said derivative as active ingredient
JP5894164B2 (ja) クロメン誘導体
JPH05506249A (ja) ビスーベンゾシクロヘプタピペリジリデン、ピペリジンおよびピペラジン化合物、組成物および使用法
JPS62267250A (ja) 抗不整脈剤
AU669206B2 (en) Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds
EP1776339B1 (en) 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
TW204347B (zh)
US6255322B1 (en) 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents
JPS5950671B2 (ja) フェニルエタノ−ルアミン誘導体およびその製造法
IE57520B1 (en) Imidazolidinedione derivatives
EP0079675A1 (en) Oxazolidinedione derivatives
EP0002867A1 (en) 5-(2-Anilinoalkylamino-1-hydroxyalkyl)salicylamides, their preparation and anti-hypertensive compositions containing them
KR100255619B1 (ko) 신규한 피페리딘 유도체 및 이의 제조방법
JPS5982375A (ja) ６−アニリノ−５，８−キノキサリンジオン類
US20020123629A1 (en) Benzothiadiazoles and derivatives
US5512566A (en) Tricyclic compounds having affinity for the 5-HT1A receptor
JPH0517441A (ja) スピロイソインドリン化合物、その製造方法、それを含有する神経症を治療するための医薬およびそれを製造するための中間体
EP2315762A2 (en) Fluoro-substituted 3,4-diaryl-4,5-dihydro-1h-pyrazole-1-carboxamidine derivatives having cb1-antagonistic activity
JPH05213885A (ja) デカヒドロキノリンの新規な誘導体、それらの製造法、製造中間体、それらの薬剤としての用途及びそれらを含有する組成物

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired